Pier Capital, LLC Repligen Corp Transaction History

Pier Capital, LLC

$666 Million
Q4 2024

A detailed history of Pier Capital, LLC transactions in Repligen Corp stock. As of the latest transaction made, Pier Capital, LLC holds 65,109 shares of RGEN stock, worth $9.57 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

65,109

Previous 64,343 1.19%

Holding current value

$9.57 Million

Previous $9.58 Million 2.13%

% of portfolio

1.41%

Previous 1.43%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$123.41 - $160.92 $94,532 - $123,264	766 Added 1.19%	65,109 $9.37 Million
Q3 2024 Nov 15, 2024	SELL	$119.79 - $167.35 $85,050 - $118,818	-710 Reduced 1.09%	64,343 $9.58 Million
Q2 2024 Aug 07, 2024	BUY	$120.0 - $182.95 $1.8 Million - $2.75 Million	15,019 Added 30.02%	65,053 $8.2 Million
Q1 2024 May 02, 2024	BUY	$170.78 - $208.42 $252,925 - $308,670	1,481 Added 3.05%	50,034 $9.2 Million
Q4 2023 Feb 15, 2024	BUY	$114.17 - $185.35 $402,791 - $653,914	3,528 Added 7.84%	48,553 $8.73 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $2.6 Million - $3.3 Million	-18,709 Reduced 29.35%	45,025 $7.16 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $2.27 Million - $2.95 Million	16,387 Added 34.61%	63,734 $9.02 Million
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $1.7 Million - $2.18 Million	10,994 Added 30.24%	47,347 $7.97 Million
Q4 2022 Feb 15, 2023	SELL	$162.42 - $220.56 $58,633 - $79,622	-361 Reduced 0.98%	36,353 $6.15 Million
Q3 2022 Nov 15, 2022	BUY	$160.42 - $256.21 $83,257 - $132,972	519 Added 1.43%	36,714 $6.87 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $903,869 - $1.21 Million	6,425 Added 21.58%	36,195 $5.88 Million
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $13,217 - $21,152	-82 Reduced 0.27%	29,770 $5.6 Million
Q4 2021 Feb 10, 2022	SELL	$247.59 - $304.47 $5,942 - $7,307	-24 Reduced 0.08%	29,852 $7.91 Million
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $904,511 - $1.51 Million	4,644 Added 18.41%	29,876 $8.63 Million
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $4.22 Million - $5.62 Million	-25,424 Reduced 50.19%	25,232 $5.04 Million
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $575,199 - $721,543	3,189 Added 6.72%	50,656 $9.85 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $239,445 - $334,023	1,617 Added 3.53%	47,467 $9.1 Million
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $91,147 - $117,752	-744 Reduced 1.6%	45,850 $6.77 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $2.71 Million - $4.04 Million	-28,775 Reduced 38.18%	46,594 $5.76 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $1.46 Million - $1.88 Million	17,208 Added 29.59%	75,369 $7.28 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $1.53 Million - $1.93 Million	-20,765 Reduced 26.31%	58,161 $5.38 Million
Q3 2019 Nov 13, 2019	SELL	$76.65 - $95.51 $2.02 Million - $2.52 Million	-26,411 Reduced 25.07%	78,926 $6.05 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $1.94 Million - $3.07 Million	-35,760 Reduced 25.34%	105,337 $9.05 Million
Q1 2019 Apr 24, 2019	BUY	$49.45 - $62.8 $873,880 - $1.11 Million	17,672 Added 14.32%	141,097 $8.34 Million
Q4 2018 Feb 13, 2019	SELL	$48.26 - $68.88 $1.3 Million - $1.85 Million	-26,917 Reduced 17.9%	123,425 $6.51 Million
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $984,250 - $1.24 Million	-21,031 Reduced 12.27%	150,342 $8.34 Million
Q2 2018 Aug 08, 2018	SELL	$35.26 - $47.04 $1.47 Million - $1.96 Million	-41,761 Reduced 19.59%	171,373 $8.06 Million
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $1.45 Million - $1.75 Million	46,939 Added 28.24%	213,134 $7.71 Million
Q4 2017 Feb 15, 2018	BUY	$32.53 - $38.92 $593,867 - $710,523	18,256 Added 12.34%	166,195 $6.03 Million
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $5.47 Million - $6.81 Million	147,939	147,939 $5.67 Million

Others Institutions Holding RGEN

# of Institutions

479

Shares Held

54.9M

Call Options Held

297K

Put Options Held

343K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.

Account